Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis (Q36128203)

12 August 2017

Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis (English)

1 reference

12 August 2017

0 references

1 reference

Eun Hye Ryu

1

1 reference

12 August 2017

Joung Mok Kim

2

1 reference

12 August 2017

Pradnya M Laddha

3

1 reference

12 August 2017

Eui-Sang Chung

4

1 reference

12 August 2017

Tae-Young Chung

5

1 reference

12 August 2017

language of work or name

1 reference

24 July 2012

1 reference

Korean Journal of Ophthalmology

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

4

1 reference

12 August 2017

241-247

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Inhibitors of the calcineurin/NFAT pathway.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Tacrolimus in heart transplantation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Tacrolimus, a new immunosuppressant--a review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3408527

Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye

23 September 2018

1 reference

12 December 2020

Glaucoma and cataract as complications to topical steroid therapy

1 reference

12 December 2020

The relation of conjunctival and corneal findings in severe ocular allergies

1 reference

12 December 2020

Clinical features of atopic keratoconjunctivitis

1 reference

12 December 2020

Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study

1 reference

12 December 2020

10.3341/KJO.2012.26.4.241

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22870021

1 reference